|
Match
|
Document |
Document Title |
|
|
6911215 |
Treating arthritis in animals with dietary supplements
The invention is a dietary supplement for animals, especially dogs, for treating arthritis and joint discomfort. A biscuit form of the supplement may be in the form of a conventional carrier...
|
|
|
6908626 |
Compositions having a combination of immediate release and controlled release characteristics
Disclosed are compositions exhibiting a combination of immediate release and controlled release characteristics. The compositions comprise at least one poorly soluble active ingredient having a...
|
|
|
6905700 |
Hydrogel entrapping therapeutic agent and stent with coating comprising this
A hydrogel forming system which comprises a hydrophobic macromer with unsaturated group terminated ends and a hydrophilic polymer which is a polysaccharide containing hydroxy groups which are...
|
|
|
6902742 |
Multiparticulate modified release composition
The invention relates to a multiparticulate modified release composition that in operation delivers an active ingredient in a pulsed or bimodal manner. The multiparticulate modified release...
|
|
|
6902741 |
Laminates containing an active substance transdermal system
The transdermal system includes a sex hormone-containing adhesive matrix, which contains inclusions of a sex hormone in a hydrophilic non-crosslinked polymer in dissolved or dispersed form. The...
|
|
|
6902739 |
Methods for treating joint inflammation, pain, and loss of mobility
This invention provides methods and formulations for treating an inflammatory disease or reducing an inflammatory reaction comprising administering a fortified formulation comprising stabilized...
|
|
|
6899891 |
Nutritional composition, methods of producing said composition and methods of using said composition
Nutritional compositions comprising at least one of aloe vera, hydrolyzed collagen, garcinia cambogia, chromium polynicotinate, chromium picolinate, chromium cruciferate, conjugated linoleic acid,...
|
|
|
6896903 |
Bioadhesive compositions
A bioadhesive composition formed by polymerizing a homogeneous aqueous reaction mixture comprising from about 5% to about 50%, by weight of the reaction mixture, of at least one ionic water soluble...
|
|
|
6893652 |
Endoparasiticidal gel composition
A homogenous, clear, veterinary gel composition which has a broad spectrum of efficacy against endoparasites over a prolonged period of time and which allows for higher concentrations of a mixture...
|
|
|
6893645 |
Process to make a sustained release formulation
This invention pertains to a process for making a sustained release complex. Compound (I), which comprises Compound (A), having formula (A), and a copolymer comprising poly...
|
|
|
6893654 |
Two-stage transmucosal medicine delivery system for symptom relief
A two-stage medicine delivery system provides an initial dose of medicine and a second dose of medicine. The initial and second doses are capable of achieving a rapid pharmacological effect and a...
|
|
|
6893662 |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a...
|
|
|
6890522 |
Cosmetic and personal care compositions
Cosmetic or personal care compositions, such as for styling hair, comprise a thermoplastic elastomer which is a block copolymer comprising a core polymer having a backbone comprising at least a...
|
|
|
6891037 |
Method for the isolation of polysaccharides
The invention relates to a method for the isolation of polysaccharides, in particular for the separation of endotoxins from capsule polysaccharides of gram-negative bacteria. The polysaccharides...
|
|
|
6890552 |
Manufacturing therapeutic enclosures
Devices and methods for enhancing the healing of wounds, especially chronic wounds (e.g., diabetic wounds), involving the use of keratinocytes are described. Keratinocytes are grown on a...
|
|
|
6887493 |
Multi component controlled release system for oral care, food products, nutraceutical, and beverages
The present invention relates to an improved controlled release system that can encapsulate different flavors, sensory markers, and active ingredients, or combinations of flavors, sensory markers...
|
|
|
6887490 |
Gene therapy vehicle comprising dermal sheath tissue
The invention herein described relates to a gene therapy vehicle, comprising dermal sheath tissue and/or cells derived from portions of hair follicles which show pluripotentiality, and which has...
|
|
|
6884434 |
Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
A transdermal therapeutic system, comprising a backing layer inert to the components of the matrix, a self-adhesive matrix layer containing...
|
|
|
6884778 |
Biocompatible macromers
A new oligomer based on alternating fumaric acid and poly(ethylene glycol) (PEG) units is provided. The oligo(PEG fumarate) (OPF) may be functionalized by modification with a biocompatible organic...
|
|
|
6884518 |
Material suitable for an individual's tissue reconstruction
A material suitable for the reconstruction of an individual's tissue, particularly supportive tissue such as bone tissue, insertable into the tissue. The material is characterized by being composed...
|
|
|
6878384 |
Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
Hydrogels that expand volumetrically in response to a change in their environment (e.g., a change in pH or temperature) and their methods of manufacture and use. Generally, the hydrogels are...
|
|
|
6875446 |
Method for prophylaxis and/or treatment of thromboembolism
A new oral IR formulation in solid form for a low molecular weight thrombin inhibitor having pH dependant dissolution, characterized in that the formulation comprises a filler or a combination of...
|
|
|
6875441 |
Composition for delivery of hematopoietic growth factor
A hematopoietic growth factor delivery composition includes a hematopoietic growth factor, a liquid vehicle, a first biocompatible polymer and a second biocompatible polymer. The composition...
|
|
|
6863902 |
Immediate release eplerenone compositions
The invention relates to oral pharmaceutical compositions useful as aldosterone receptor blockers comprising the active agent micronized eplerenone in an amount of about 10 mg to about 1000 mg and...
|
|
|
6858229 |
In situ forming hydrogels
The invention features materials and methods for the liquid to solid transition of an injectable pre-hydrogel composition to a hydrogel. These methods can be carried out in situ.
|
|
|
6855333 |
Stabilization of solid thyroid drug formulations
Pharmaceutical formulations and dosage forms are provided having improved stability to moisture-induced degradation when compared with conventional dosage forms, especially tablets. The invention...
|
|
|
6846491 |
Clear, polymeric gel composition and method for producing the same
Disclosed is a clear, crosslinked, polymeric gel composition that is the reaction product of a microemulsion containing (a) from 1-70 wt. %, preferably from 1-40 wt. %, and more preferably from...
|
|
|
6846495 |
Compositions having improved delivery of actives
The present invention pertains to compositions having improved delivery of pharmaceutical actives. These compositions comprise pharmaceutical actives in an anhydrous solvent. These compositions may...
|
|
|
6846837 |
Topical administration of basic antifungal compositions to treat fungal infections of the nails
Methods and topical pharmaceutical formulations are provided for the treatment of nail fungus (onychomycosis). The invention involves a pharmacologically active antifungal agent, plus a...
|
|
|
6844005 |
Electrostatically charged nasal application product with increased strength
The present invention relates to a nasal topical application product for restricting the flow of airborne contaminants into a human nasal passage by creation of a proximate, enhanced electrostatic...
|
|
|
6841574 |
Topical stabilized prostaglandin E compound dosage forms
Compounds of prostaglandin E group (PGE compounds) are stabilized as non-aqueous compositions that include the compound together with a bulking agent that can be a non-aqueous liquid or a solid in...
|
|
|
6841168 |
Method for the preservation of biologically-active material
Biologically-active material can be preserved by a method of desiccation, without lyophilisation, in a matrix of glassy trehalose. The method involves forming a coacervate of the...
|
|
|
6841393 |
Selective removal of contaminants from a surface using colored particles and articles having magnets
A system and method for removing contaminants from a surface. The system is designed to use very small particles having means thereon which are capable of selectively binding to a contaminant or...
|
|
|
6838093 |
System for osmotic delivery of pharmaceutically active agents
An osmotic system for delivering a pharmaceutically active agent which comprises a core portion, a layer portion enclosing the core portion, and a semipermeable wall portion enclosing the core...
|
|
|
6835386 |
Collar containing a novel gel formulation to control arthropod infestation of animals
The present invention provides a device, preferably a collar or ear tag, capable of the controlled, sustained release of an effective amount of an active ingredient that can protect an animal...
|
|
|
6827930 |
System for attracting fish
A sport fishing system having: a rod and reel, including fishing line; at least one fishing lure or natural bait; and a controlled released fish attractant for applying to the fishing lure or...
|
|
|
6828412 |
Degradable polymers
A polymer comprising: a polymeric backbone comprising at least one unit having the structure (I), wherein R-R 4 comprise groups selected from the group consisting of H, C 1 -C 12 alkyl, C 6 -C 18...
|
|
|
6824792 |
Bioadhesive composition
This invention relates to a method of producing a bioadhesive composition comprising the steps of preparing a solution of a solvent and a polymer mixture wherein the polymer mixture comprises at...
|
|
|
6818224 |
Use of gellable pharmaceutical compositions in periodontology
A method is described for preparing a fluid pharmaceutical composition which allows the controlled release of at least one active substance. The method involves mixing a therapeutically effective...
|
|
|
6814981 |
Ganglioside immunostimulating complexes and uses thereof
An immunostimulating complex comprising one or more ganglosides, illustrated by the ganglosides GM2, GD2, GD3 or GT3, is useful as a prophylactic or therapeutic agent in the treatment of tumors,...
|
|
|
6808707 |
Wound healing compositions and methods using tropoelastin and lysyl oxidase
The present invention provides compositions and methods for promoting wound healing. The composition comprises virgin monomers of tropoelastin and lysyl oxidase. When the lysyl oxidase comes in...
|
|
|
6800296 |
Modification of surfaces using biological recognition events
The present invention provides a novel surface engineering strategy that uses biomolecular interactions to immobilize surface modifying ligands on biomaterial architectures. The surface modified...
|
|
|
6800297 |
Porous COX-2 inhibitor matrices and methods of manufacture thereof
One or more COX-2 inhibitors are provided in a porous matrix form wherein the dissolution rate of the drug is enhanced when the matrix is contacted with an aqueous medium. The porous matrix yields...
|
|
|
6797283 |
Gastric retention dosage form having multiple layers
The present invention is directed to a multilayered dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent to a fluid environment of use....
|
|
|
6793938 |
Biodegradable compositions for the controlled release of encapsulated substances
Pharmaceutical compositions that enable the release of a physiologically active substance over a prolonged period of time following administration to a patient are described. The pharmaceutical...
|
|
|
6790453 |
Encapsulation compositions and process for preparing the same
Encapsulation compositions in which an encapsulate (A) is encapsulated in a matrix (B) may be prepared by: (i) mixing matrix (B) with a liquid plasticizer and encapsulate (A) in an extruder, to...
|
|
|
6790436 |
Gel air freshener
Described is a substantially rigid aqueous clear gel matrix air freshener article having included therein one or more gel matrix icons, the dimensions of which, on use of the article, decrease in...
|
|
|
6787529 |
Topical composition
The present invention relates to a pharmaceutical gel composition for application on skin, said composition comprising at least one vitamin D or vitamin D analogue and at least one corticosteroid...
|
|
|
6783772 |
Pharmaceutical preparations containing alendronate sodium
An oral composition in tablet form containing therapeutic amounts of alendronate sodium for release of the alendronate sodium in the stomach and by passing the oesophagus, comprising a compacted...
|
|
|
6783769 |
Transdermal therapeutic system TTS containing tolterodine
The invention relates to a transdermal therapeutic system (TTS) for transcutaneously administering tolterodine over a period of several days and to a method for producing the same. The TTS contains...
|